Data from Palbociclib Rechallenge for Hormone Receptor–Positive/HER-Negative Advanced Breast Cancer: Findings from the Phase II BioPER Trial

MLA

Antonio Llombart-Cussac, et al. Data from Palbociclib Rechallenge for Hormone Receptor–Positive/HER-Negative Advanced Breast Cancer: Findings from the Phase II BioPER Trial. Apr. 2023. EBSCOhost, https://doi.org/10.1158/1078-0432.c.6532953.

APA

Antonio Llombart-Cussac, Javier Cortés, Andrea Malfettone, Crina Popa, Miguel Sampayo-Cordero, Silvia Menéndez, Federico Rojo, Beatriz Bellosillo, Leonardo Mina, Ana Santaballa Bertran, Vanesa Quiroga, Alessandro Marco Minisini, Enrique Espinosa, Juan de la Haba, Lourdes Calvo, Begoña Bermejo, Meritxell Bellet, Joan Gibert, Laura Comerma, … Joan Albanell. (2023). Data from Palbociclib Rechallenge for Hormone Receptor–Positive/HER-Negative Advanced Breast Cancer: Findings from the Phase II BioPER Trial. https://doi.org/10.1158/1078-0432.c.6532953

Chicago

Antonio Llombart-Cussac, Javier Cortés, Andrea Malfettone, Crina Popa, Miguel Sampayo-Cordero, Silvia Menéndez, Federico Rojo, et al. 2023. “Data from Palbociclib Rechallenge for Hormone Receptor–Positive/HER-Negative Advanced Breast Cancer: Findings from the Phase II BioPER Trial,” April. doi:10.1158/1078-0432.c.6532953.